XML 66 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Fair Value Measurements
3 Months Ended
Mar. 31, 2014
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments and Fair Value Measurements
Financial Instruments and Fair Value Measurements
The Company invests a portion of its cash in certificates of deposit, corporate notes, commercial paper, U.S. government treasury securities and securities of government-sponsored entities. The Company classifies all securities as available-for-sale, as the sale of such securities may be required prior to maturity to implement management strategies. These securities are carried at fair value, with the unrealized gains and losses reported as a component of other comprehensive income in equity until realized. Realized gains and losses and declines in value judged to be other-than-temporary, if any, on available-for-sale securities are included in other income or expense on the condensed consolidated statements of operations. As of March 31, 2014, the Company had no investments that were in a significant unrealized loss position and no impairment charges were recorded during the periods presented. If an investment is deemed other than temporarily impaired, the impairment is charged to earnings and a new cost basis for the security is established. The Company reviews its investments to identify and evaluate investments that have an indication of possible other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include the length of time and extent to which fair value has been less than the cost basis, the financial condition and near-term prospects of the investee, and the Company’s intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value.
Premiums and discounts are amortized or accreted over the life of the related security as an adjustment to yield using the straight-line method and are included in interest income on the condensed consolidated statements of operations. Interest and dividends on securities classified as available-for-sale are also included in interest income on the condensed consolidated statements of operations. Realized gains and losses and interest income and expense related to marketable securities were immaterial during all periods presented.
According to the Company's investment policy, the Company maintains a diversified investment portfolio in terms of types, maturities, and credit exposure, and it requires the Company to invest with institutions that have high credit quality. The Company does not currently hold derivative financial investments or speculative investments. The carrying amounts of other financial instruments such as cash equivalents, accounts receivable, prepaid expenses, other current assets, accounts payable, accrued expenses, and other current liabilities as of March 31, 2014 and December 31, 2013 approximate their related fair values due to the short-term maturities of these instruments. The estimated fair value of the Company’s capital lease obligations approximated their carrying values. The fair value and carrying value of the Company’s Senior Convertible Notes is discussed in Note 6.
The fair value, based on a quoted market price, (Level 1), of the outstanding 2017 Notes at March 31, 2014 and December 31, 2013 was approximately $476.0 million and $439.3 million, respectively.
The composition of marketable securities is as follows (in thousands, except years):
 
Contractual
Maturity
(in Years)
 
Amortized Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
March 31, 2014:
 
 
 
 
 
 
 
 
 
Classified as current assets
 
 
 
 
 
 
 
 
 
Certificates of deposit
Less than 1
 
$
832

 
$

 
$

 
$
832

Corporate notes
Less than 1
 
95,983

 
32

 
(23
)
 
95,992

Commercial paper
Less than 1
 
19,985

 

 

 
19,985

U.S. government treasury securities
Less than 1
 
1,500

 
2

 

 
1,502

Securities of government-sponsored entities
Less than 1
 
58,278

 
34

 
(15
)
 
58,297

Short-term marketable securities
 
 
176,578

 
68

 
(38
)
 
176,608

Classified as non-current assets
 
 
 
 
 
 
 
 
 
Certificates of deposit
1 to 2
 
283

 

 

 
283

Corporate notes
1 to 2
 
32,842

 
11

 
(45
)
 
32,808

Securities of government-sponsored entities
1 to 2
 
19,104

 
18

 
(4
)
 
19,118

Long-term marketable securities
 
 
52,229

 
29

 
(49
)
 
52,209

Classified as restricted investments
 
 
 
 
 
 
 
 
 
U.S. government treasury securities
Less than 2
 
40,456

 
30

 
(2
)
 
40,484

Securities of government-sponsored entities
Less than 2
 
28,108

 
5

 
(18
)
 
28,095

Restricted investments
 
 
68,564

 
35

 
(20
)
 
68,579

Total marketable securities at March 31, 2014
 
 
$
297,371

 
$
132

 
$
(107
)
 
$
297,396

 
 
 
 
 
 
 
 
 
 
December 31, 2013:
 
 
 
 
 
 
 
 
 
Classified as current assets
 
 
 
 
 
 
 
 
 
Certificates of deposit
Less than 1
 
$
833

 
$

 
$

 
$
833

Corporate notes
Less than 1
 
71,611

 
23

 
(6
)
 
71,628

Commercial paper
Less than 1
 
19,973

 

 

 
19,973

U.S. government treasury securities
Less than 1
 
7,603

 
2

 

 
7,605

Securities of government-sponsored entities
Less than 1
 
43,405

 
14

 
(9
)
 
43,410

Short-term marketable securities
 
 
143,425

 
39

 
(15
)
 
143,449

Classified as non-current assets
 
 
 
 
 
 
 
 
 
Certificates of deposit
1 to 2
 
283

 

 

 
283

Corporate notes
1 to 2
 
32,309

 
23

 
(14
)
 
32,318

U.S. government treasury securities
1 to 2
 
1,500

 
1

 

 
1,501

Securities of government-sponsored entities
1 to 2
 
45,722

 
19

 
(14
)
 
45,727

Long-term marketable securities
 
 
79,814

 
43

 
(28
)
 
79,829

Classified as restricted investments
 
 
 
 
 
 
 
 
 
U.S. government treasury securities
Less than 2
 
43,274

 
16

 
(6
)
 
43,284

Securities of government-sponsored entities
Less than 2
 
29,125

 
4

 
(16
)
 
29,113

Restricted investments
 
 
72,399

 
20

 
(22
)
 
72,397

Total marketable securities at December 31, 2013
 
 
$
295,638

 
$
102

 
$
(65
)
 
$
295,675


The Company measures certain assets and liabilities in accordance with authoritative guidance which requires fair value measurements be classified and disclosed in one of the following three categories:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.
Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
Level 3: Unobservable inputs are used when little or no market data is available.
Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between Level 1 and Level 2 of the fair value measurement hierarchy during the three months ended March 31, 2014 and 2013.
The fair values of the Company’s assets and liabilities, which are measured at fair value on a recurring basis, were determined using the following inputs (in thousands):
 
Total
 
Quoted Price in
Active Market
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs (Level 3)
March 31, 2014:
 
 
 
 
 
 
 
Cash Equivalents, Marketable Securities and Restricted Investments:
 
 
 
 
 
 
 
Money market funds
$
59,433

 
$
59,433

 
$

 
$

Certificates of deposit
1,115

 
1,115

 

 

Corporate notes
128,800

 

 
128,800

 

Commercial paper
19,985

 

 
19,985

 

U.S. government treasury securities
41,986

 
41,986

 

 

Securities of government-sponsored entities
105,510

 

 
105,510

 

Total cash equivalents, marketable securities and restricted investments
$
356,829

 
$
102,534

 
$
254,295

 
$

 
 
 
 
 
 
 
 
Contingent Consideration:
 
 
 
 
 
 
 
Acquisition-related liabilities, current
$
(604
)
 
$

 
$

 
$
(604
)
Total contingent consideration
$
(604
)
 
$

 
$

 
$
(604
)
 
 
 
 
 
 
 
 
December 31, 2013:
 
 
 
 
 
 
 
Cash Equivalents, Marketable Securities and Restricted Investments:
 
 
 
 
 
 
 
Money market funds
$
72,514

 
$
72,514

 
$

 
$

Certificates of deposit
1,116

 
1,116

 

 

Corporate notes
103,946

 

 
103,946

 

Commercial paper
19,973

 

 
19,973

 

U.S. government treasury securities
52,390

 
52,390

 

 

Securities of government-sponsored entities
118,250

 

 
118,250

 

Total cash equivalents, marketable securities and restricted investments
$
368,189

 
$
126,020

 
$
242,169

 
$

 
 
 
 
 
 
 
 
Contingent Consideration:
 
 
 
 
 
 
 
Acquisition-related liabilities, current
$
(616
)
 
$

 
$

 
$
(616
)
Acquisition-related liabilities, non-current
$
(596
)
 
$

 
$

 
$
(596
)
Total contingent consideration
$
(1,212
)
 
$

 
$

 
$
(1,212
)

Contingent Consideration Liability
In connection with an immaterial acquisition in 2012, the Company is required to pay an amount not to exceed €2.0 million in the event two specified revenue-based milestones are met. The fair value of the contingent consideration was determined using a discounted cash flow model, the significant inputs of which are not observable in the market. The key assumptions in applying this approach are the revenue projections, the interest rate and the probabilities assigned to the milestones being achieved. Based on these assumptions, the estimated fair value of the contingent consideration totaled $0.6 million at March 31, 2014 and is included in accrued liabilities in the March 31, 2014 condensed consolidated balance sheet. Changes in fair value are recorded in the statements of operations as sales, marketing and administrative expenses.

The following table sets forth the changes in the estimated fair value of the Company’s liabilities measured on a recurring basis using significant unobservable inputs (Level 3) (in thousands):
 
Three Months Ended March 31,
 
2014
 
2013
Fair value measurement at beginning of period
$
1,212

 
$
1,074

Change in fair value measurement included in operating expenses

 
(17
)
Contingent consideration paid or settled
(608
)
 

Fair value measurement at end of period
$
604

 
$
1,057